Shanghai-headquartered biopharma I-Mab has signed a partnership with pharma giant AbbVie. The deal centres around further developing and commercialising I-Mab’s novel cluster of differentiation 47 (CD47) monoclonal antibody lemzoparlimab for...
Plasma Rx leads as Pharmaceutical Technology lists ten of the most popular tweets on infectious disease in August 2020 based…
Scenic Biotech has entered into a multi-year strategic partnership with Roche unit Genentech in a bid to discover, develop and commercialise new drugs against genetic…
Bausch Health has signed an agreement to acquire an option to buy biopharmaceutical company Allegro Ophthalmics’ ophthalmological assets. The option will include worldwide rights to…
South Korea-based biopharmaceutical services provider Samsung Biologics has signed a long-term supply agreement, valued at approximately $330.8m, with AstraZeneca. Under…
Roche has completed a share purchase agreement to acquire Irish biotech firm Inflazome for an upfront payment of $449m (€380m).…
Sanofi and GlaxoSmithKline (GSK) have signed an advanced purchase agreement with the European Commission (EC) to supply up to 300…
Russia has granted marketing authorisation for R-Pharm’s Covid-19 prescription drug, Coronavir, to treat outpatients with mild to moderate infection. The…
On 13 September, Gilead announced the acquisition of the biopharmaceutical company Immunomedics for $21B, as the pharma giant looks to bolster its cancer portfolio, specifically targeting Immunomedics’ lead product, Trodelvy…
Countries across Europe including the UK, Spain and France are witnessing a surge in the number of Covid-19 cases. Some of these countries have just started showing signs of economic…
The UK is facing resurgence in cases forcing the government to take drastic measures to curb the infection rates. A new set of restrictions and the possibility of another national…
From 'Europe's digital decade', to the $40bn sale of ARM, here are the key developments so far this week. NS...
From AWS’s fury over Microsoft’s $10bn Pentagon cloud deal, to a new £50m fund for AI-powered healthcare products, Oscar Williams finds the five key developments...
From the government's plans to overhaul digital identity, to HMRC's new CDIO, here are the key stories so far this week.
Robert McNutt is the CTO of Forescout, a cybersecurity company that specialises in protecting the 'enterprise of things'.
Microfluidic Platforms for Automated Sample Preparation of Biological Samples for the Life Sciences Industry
Consulting Services for Compliance in Pharmaceutical Quality Management Systems and General Process Optimisation
Twitter round-up: Peter Hotez’s tweet on Emergency Use Authorization for plasma Rx most popular in August 2020
Plasma Rx leads as Pharmaceutical Technology lists ten of the most popular tweets on infectious disease in August 2020 based on data from GlobalData’s Influencer Platform. The top tweets were…